NABP FPGEE Foreign Pharmacy Graduate Equivalency Examination Online Training
NABP FPGEE Online Training
The questions for FPGEE were last updated at Apr 01,2025.
- Exam Code: FPGEE
- Exam Name: Foreign Pharmacy Graduate Equivalency Examination
- Certification Provider: NABP
- Latest update: Apr 01,2025
Question #11
Indication of clindamycin is:
- A . Benzodiazepine intoxication
- B . Hypercalcemia
- C . Kaposi’s sarcoma
- D . Streptococcus pneumoniae
- E . Angina
Question #12
Mechanism of action of vincristine is:
- A . Inhibits organification of iodine by thyroid gland
- B . Increases peripheral tissues sensitivity to insulin
- C . Reduces peripheral insulin resistance
- D . Inhibits Na-K-2Cl transporter
- E . Mitotic spindle poison
Question #13
Class of metformin is:
- A . Lipid lowering drugs
- B . Antimycobacterial
- C . Thyroid agents
- D . Vasodilators
- E . Oral hypoglycemics
Question #14
Which of the following is not related to a drug toxicity of Prednisone?
- A . Cataracts
- B . Hypotension
- C . Psychosis
- D . Acne
Question #15
Effect of bisacodyl is:
- A . Decreases total cholesterol by 8-12%
- B . Decreases water absorption
- C . Decreases total cholesterol by 20-50%
- D . Enhances mucociliary clearance
- E . Decreases triglycerides by 10-20%
Question #16
Class of nystatin is:
- A . Thiazides
- B . Antiprotozoan agents
- C . Autonomic nervous system drugs
- D . Polyenes
- E . Oral hypoglycemics
Question #17
Site of metabolism of zolpidem is:
- A . Liver
- B . None
- C . Reticuloendothelial system
- D . Leukocytes
- E . Unknown
Question #18
Mechanism of action of amiloride is:
- A . Inhibits dihydrofolate reductase
- B . Modulation of CD3 receptor from the cell surface
- C . Inhibits renal epithelial Na channels
- D . Aldosterone antagonist
- E . Inhibits DNA-dependent RNA polymerase
Question #19
Side effect of dipyridamole is:
- A . Diarrhea
- B . Headache
- C . Bleeding
- D . Hypercalcemia
- E . Pseudothrombocytopenia (clumping of platelets)
Question #20
Mechanism of resistance of Invirase is:
- A . Mutation of viral DNA polymerase
- B . Mutations of viral protease
- C . Mutation of thymidilate synthase decreasing its affinity for the drug’s active metabolite
- D . Tolerance
- E . Mutation of viral reverse transcriptase